Medifast, Inc. (MED) Shareholders’ equity 2016–2025
Medifast, Inc. (MED) shareholders’ equity at each fiscal year-end, per SEC filings.
$198.9MFY2025 · since FY2016: $96.0M → $198.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $198.9M | -5.3% |
| FY2024 | $210.1M | +4.3% |
| FY2023 | $201.5M | +30.0% |
| FY2022 | $155.0M | -23.4% |
| FY2021 | $202.5M | +28.8% |
| FY2020 | $157.2M | +50.0% |
| FY2019 | $104.8M | -3.9% |
| FY2018 | $109.1M | +2.4% |
| FY2017 | $106.6M | +11.0% |
| FY2016 | $96.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice